Literature DB >> 23483632

Recent advances in the management of choreas.

Jean-Marc Burgunder1.   

Abstract

The management of patients with chorea, in particular Huntington's disease, is a complex task requiring skills in a number of areas. This paper reviews new knowledge on this topic and places it in the context of established procedures. It is focused on Huntington's disease, since this is the disorder, for which most publications on management have been published in the past few years. Management starts with appropriate diagnosis and differential diagnosis, with the aim of finding disorders with chorea amenable to causative treatment. The place of genetic testing and the importance of genetic counselling is stressed, as well as the importance of precise observation in the course of the disorder to tailor appropriate therapies. Pharmacological treatment is based on poor evidence but to a large extent on expertise from centres devoted to the care of patients with Huntington's disease. It is focused mainly on motor and psychiatric aspects of the phenotype. Nonpharmacological treatment is important and is best offered in a multidisciplinary care setting.

Entities:  

Keywords:  Chorea; Huntington’s disease; diagnosis; management; treatment

Year:  2013        PMID: 23483632      PMCID: PMC3582311          DOI: 10.1177/1756285612471700

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  61 in total

1.  Huntington's Disease-like 2 (HDL2) in North America and Japan.

Authors:  Russell L Margolis; Susan E Holmes; Adam Rosenblatt; Lisa Gourley; Elizabeth O'Hearn; Christopher A Ross; William K Seltzer; Ruth H Walker; Tetsuo Ashizawa; Astrid Rasmussen; Michael Hayden; Elisabeth W Almqvist; Juliette Harris; Stanley Fahn; Marcy E MacDonald; Jayalakshmi Mysore; Takayoshi Shimohata; Shoji Tsuji; Nicholas Potter; Kazuhiro Nakaso; Yoshiki Adachi; Kenji Nakashima; Thomas Bird; Amanda Krause; Penny Greenstein
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

Review 2.  A systematic review of the treatment studies in Huntington's disease since 1990.

Authors:  Raphael M Bonelli; Peter Hofmann
Journal:  Expert Opin Pharmacother       Date:  2007-02       Impact factor: 3.889

3.  Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities.

Authors:  Karin F Hoth; Jane S Paulsen; David J Moser; Daniel Tranel; Lee Anna Clark; Antoine Bechara
Journal:  J Clin Exp Neuropsychol       Date:  2007-05       Impact factor: 2.475

4.  Chorea in an 83-year-old woman: don't forget Huntington's disease.

Authors:  Romain Lefaucheur; Lucie Guyant-Maréchal; David Wallon; Gaël Nicolas; Alaina Borden; David Maltête; Eléonore Tollard
Journal:  J Am Geriatr Soc       Date:  2012-05       Impact factor: 5.562

5.  Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.

Authors:  Wan-Jin Chen; Yu Lin; Zhi-Qi Xiong; Wei Wei; Wang Ni; Guo-He Tan; Shun-Ling Guo; Jin He; Ya-Fang Chen; Qi-Jie Zhang; Hong-Fu Li; Yi Lin; Shen-Xing Murong; Jianfeng Xu; Ning Wang; Zhi-Ying Wu
Journal:  Nat Genet       Date:  2011-11-20       Impact factor: 38.330

6.  Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume.

Authors:  Gaël Nicolas; Didier Devys; Alice Goldenberg; David Maltête; Catherine Hervé; Didier Hannequin; Lucie Guyant-Maréchal
Journal:  Am J Med Genet A       Date:  2011-03-15       Impact factor: 2.802

Review 7.  The differential diagnosis of chorea.

Authors:  E J Wild; S J Tabrizi
Journal:  Pract Neurol       Date:  2007-11

8.  Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.

Authors:  Pascale Ribaï; Karine Nguyen; Valérie Hahn-Barma; Isabelle Gourfinkel-An; Marie Vidailhet; Antoine Legout; Catherine Dodé; Alexis Brice; Alexandra Dürr
Journal:  Arch Neurol       Date:  2007-06

9.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Authors:  Sarah J Tabrizi; Douglas R Langbehn; Blair R Leavitt; Raymund Ac Roos; Alexandra Durr; David Craufurd; Christopher Kennard; Stephen L Hicks; Nick C Fox; Rachael I Scahill; Beth Borowsky; Allan J Tobin; H Diana Rosas; Hans Johnson; Ralf Reilmann; Bernhard Landwehrmeyer; Julie C Stout
Journal:  Lancet Neurol       Date:  2009-07-29       Impact factor: 44.182

10.  An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.

Authors:  Jean-Marc Burgunder; Mark Guttman; Susan Perlman; Nathan Goodman; Daniel P van Kammen; Lavonne Goodman
Journal:  PLoS Curr       Date:  2011-08-30
View more
  3 in total

Review 1.  Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.

Authors:  Emma M Coppen; Raymund A C Roos
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

2.  Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease.

Authors:  Roland Wiest; Jean-Marc Burgunder; Claus Kiefer
Journal:  Front Neurol       Date:  2017-09-06       Impact factor: 4.003

3.  Translational research in Huntington's disease: opening up for disease modifying treatment.

Authors:  Jean-Marc Burgunder
Journal:  Transl Neurodegener       Date:  2013-01-25       Impact factor: 8.014

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.